Personalis, Inc. reported $65M of revenue over the trailing twelve months, −25% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $65M (to Q1 2026). Net Income: −$96M, trailing twelve months to Q1 2026. Free Cash Flow: −$85M, trailing twelve months to Q1 2026. Op Margin: −160%, trailing twelve months to Q1 2026.

PSNLPersonalis, Inc.

HealthcareUSD

$17.06

$4.5052 weeks$18.41

PSNL as reported

Personalis, Inc. reported $65M of revenue over the trailing twelve months, −25% on the year before. 9 reported series are charted on this page, each one as filed.

$65M

Revenue, trailing twelve months · to Q1 2026 · −25% against the twelve months before

Net Income: −$96M
Net Income · +14% year on year · trailing twelve months to Q1 2026
Free Cash Flow: −$85M
Free Cash Flow · +81% year on year · trailing twelve months to Q1 2026
Op Margin: −160%
Op Margin · trailing twelve months to Q1 2026

Every series Ryufin has for PSNL, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$65M	−25%	Q1 2026
Net Income	−$96M	+14%	Q1 2026
EPS	−$1.02	−18%	Q1 2026
Gross Margin	13%	n/a	Q1 2026
Op Margin	−160%	n/a	Q1 2026
Net Margin	−149%	n/a	Q1 2026
ROE	−40%	n/a	Q1 2026
ROA	−30%	n/a	Q1 2026
Free Cash Flow	−$85M	+81%	Q1 2026